Chapter 17
Chapter 17
17
Regulation of Gene
Expression in
Eukaryotes
Lecture Presentation by
Dr. Cindy Malone,
California State University Northridge
continued
Chromosome territory
– In interphase nucleus, each chromosome
occupies discrete domain and stays separate
from other chromosomes
– Interchromosomal domains
Channels between chromosomes that contain little or
no DNA
Chromosome structure is continuously
rearranged; transcriptionally active genes are
cycled to edges of chromosome territories
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829961/
https://link.springer.com/protocol/10.1007/978-1-62703-284-1_2
Transcription factories
– Feature within nucleus that may contribute to
gene expression
– Nuclear sites that contain most of the active RNA
polymerase and transcription regulatory
molecules
– Dynamic structures that form rapidly and
disassemble upon stimulation and repression of
transcription
Histone modification
– Covalent bonding of functional groups onto N-
terminal tails of histone proteins
Most common: acetyl, methyl, phosphate
– Acetylation decreases positive charge, which
reduces affinity of histone to DNA
– Histone acetylation of nucleosome is catalyzed by
histone acetyltransferase enzymes (HATs):
associated with increased transcription
(Figure 17-2)
Chromatin remodeling
– Involves repositioning or removal of nucleosomes
on DNA
– Repositioned nucleosomes make chromosome
regions accessible to
Transcription regulatory proteins
Transcription activators
RNAP II (RNA polymerase II)
SWI/SNF
– One of the best-studied remodeling complexes
– Loosens attachment between histone and DNA
– Loosens DNA strand from nucleosome core
– Causes reorganization of internal nucleosome
components
(Figure 17-2)
DNA methylation
– Associated with decreased gene expression
– Methylation occurs most often on cytosine of CG
doublets in DNA
– Methylation can repress transcription by binding
to transcription factors of DNA
Cis-acting sequence
– Located on same chromosome as gene that it
regulates
– Required for accurate regulated transcription of
genes
Promoters
Enhancers
Silencers
Promoter structure
– Made up of DNA sequence elements including:
Initiator (Inr)
TATA box
TFIIB recognition element (BRE)
Downstream promoter element (DPE)
Motif ten element (MTE)
General transcription factors (GTFs) bind to specific sequence elements in the promoter. These elements (the B recognition element (BRE), the TATA box (TATA), the initiator (Inr), the motif ten element
(MTE) and the downstream promoter element (DPE)) and their approximate locations relative to the transcription start site (TSS, black arrow) are shown 2. Transcriptional regulators (orange oval and
yellow diamond), which are either activators or repressors, bind to specific DNA sequences located near the core promoter of the gene or various distant regions, called enhancers. The regulators can
interact (green arrows) with GTFs, such as TFIID (blue rectangle) and TATA-binding protein (TBP, blue horseshoe), and the Pol II complex (red 'rocket') to enhance or repress transcription. They also
interact (green arrows) with co-regulators (green hexagon) that can interact (blue arrows) with the general ranscription machinery or chromatin-modifying factors, such as histone modifiers or nucleosome
remodellers. The co-regulators can also bind to nucleosomes (green) with various histone modifications, stabilizing the co-regulator binding to the gene.
Activators can recruit, stabilize or stimulate these factors, and repressors can disrupt or inhibit these factors.
Transcription factors
– Transcription regulatory proteins
– Target cis-acting sites of genes regulating
expression
– Activators increase transcription initiation
– Repressors decrease transcription initiation
Multiple transcription factors bind to several
different enhancers and promoter elements and
fine-tune the level of transcription initiation
Product of hMTIIA
– Protein that binds to heavy metals and protects
cells from toxic effects
– Protects cells from oxidative stress
– Expressed in low levels in all cells
– Transcribed at high levels when exposed to
heavy metals
(Figure 17-6)
Gal4 protein
Encoded by GAL4 gene
– Negatively regulated by
Gal80 protein
Has DNA-binding
domain that recognizes
and binds to sequences
in UASG
Binding of
phosphorylated
galactose to Gal80p
and/or Gal4p exposes
activation domain of
Gal4p
(Figure 17-10)
© 2017 Pearson Education, Ltd.
Deletion mutants
were pivotal to
delineate
functional
regions
Then mediator
complex interacts
with Gal4p/SAGA to
recruit RNA pol II
https://www.sciencedirect.com/science/article/pii/
S1097276517306135
17.7 Posttranscriptional Gene Regulation
Occurs at Many Steps from RNA
Processing to Protein Modification
G is the co-factor!
OH of A attacks
The G, whose OH attacks
The other G (Exon2)
Not autocatalytic
Needs
SPLICEOSOME
Alternative splicing
– Generates different forms of mRNA from identical
pre-mRNA (increases number of proteins)
– Expression of one gene gives rise to numerous
proteins with similar and different functions
– Increases number of proteins made from one
gene (Figure 17-11 and Figure 17-12)
Alternative splicing
– Number of proteins cell can make (proteome) is
not directly related to number of genes in genome
– At least two-thirds of protein-coding genes in
humans undergo alternative splicing
• Cells 8(8):778DOI:
• 10.3390/cells8080778
Pathways of degradation
1) Enzymes shorten length of poly-A tail
• Binding of poly-A binding protein to tail stabilizes
mRNA
2) Decapping enzymes removes 7-methylguanine
cap – mRNA now unstable
3) Endonuclease cleaves mRNA internally
https://www.youtube.com/watch?v=5YsTW5i0Xro
RNAi in biotechnology
– RNAi studied in lab
– Developed as pharmaceutical agent
– Therapeutic RNAi attacks diseases caused by
overexpression of specific gene or normal
expression of abnormal gene product
– Potential use of RNAi in diagnosis of cancers
– RNAi reduces severity of infections by viruses
such as HIV, influenza, and polio